Pouzdanost dijagnoze bazocelularnog karcinoma u dermatologiji – monocentrična studija u Srbiji
Sažetak
Uvod/Cilj. Zbog povećane incidence tumora kože potrebna je njihova pouzdana dijagnoza. Dermoskopija, posebno in vivo, poboljšava dijagnozu bazocelularnog karcinoma (BCK). Pregled kompletne kože tela (PKKT) podrazumeva inspekciju cele površine kože bolesnika i predstavlja osnov dermatološkog pregleda, a posebno pregleda „skrininga” kože na premaligne i maligne lezije. Međutim, svrsishodnost PKKT u svakodnevnoj kliničkoj praksi je i dalje predment debate. Cilj rada bio je da se ispita pouzdanost dijagnostike BCK, detektovanog i lečenog od strane iskusnog dermatologa. Metode. Retrospektivna analiza obuhvatila je petogodišnji period detekcije BCK prilikom PKKT vizuelnom ispekcijom i dermoskopskim pregledom. Određivana je senzitivnost, specifičnost i pozitivna prediktivna vrednost dijagnoze BCK korišćenjem histopatoloških rezultata kao tačne dijagnoze. Rezultati. Od 3 346 bioptiranih tumora kože, 49,58% su bili maligni a 50,42% benigni. Najčešći maligini tumor bio je BCK (84,09%). Njegova najčešća lokalizacija je bio trup (38,92%) i H-regija lica (37,63%). Ostale lokalizacije bile su: lice (izvan H-regiona) (6,67%), vrat (3,01%), poglavina (3,37%), ruke (6,88%) i noge (3,51%). Od ukupnog broja BCK, 0,83% su bili recidivantni. Senzitivnost dijagnostike BCK iznosila je 97,71%, a pozitivna prediktivna vrednost bila je 95,08%. Zaključak. U dermatologiji, PKKT vizuelnom ispekcijom i in vivo dermoskopijom omogućava veoma dobru dijagnostiku BCK.
Reference
Ilić D, Videnović G, Kozomara R, Radaković SS, Vlahović Z, Mat-vijenko V, Živković S. Non-melanoma skin cancer in Serbia 1999-2015 – the need for national prevention strategy and control. Vojnosanit Pregl 2020; 77(11): 1154‒60.
Mijušković ŽP. Etiology and pathogenesis of basal cell carcino-ma. Serb J Dermatol Venereol 2013; 5(3): 113‒24.
Roš T, Gajić B, Rajić N, Ivkov-Simić M, Gajinov Z. Basal cell car-cinoma: a frequent challenge. Serb J Dermatol Venereol 2012; 4(1): 5‒17.
Heal CF, Raasch BA, Buettner PG, Weedon D. Accuracy of clin-ical diagnosis of skin lesions. Br J Dermatol 2008; 159(3): 661–8.
Youl PH, Baade PD, Janda M, Del Mar CB, Whiteman DC, Ait-ken JF. Diagnosing skin cancer in primary care: how do main-stream general practitioners compare with primary care skin cancer clinic doctors? MJA 2007; 187(4): 215–20.
Ek EW, Giorlando F, Su SY, Dieu T. Clinical diagnosis of skin tumours: how good are we? ANZ J Surg 2005; 75(6): 415–20.
Argenziano G, Soyer HP, Chimenti S, Talamin R, Corona R, Sera F, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003; 48(5): 679–93.
Lallas A, Apalla Z, Argenziano G, Longo C, Moscarella E, Spec-chio F, Raucci M, Zalaudek I. The dermatoscopic universe of ba-sal cell carcinoma. Dermatol Pract Concept 2013; 4(3): 11‒24.
Suppa M, Micantonio T, Di Stefani A, Soyer HP, Chimenti S, Fargnoli MC, et al. Dermoscopic variability of basal cell carci-noma according to clinical type and anatomic location. J Eur Acad Dermatol Venereol 2015; 29(9): 1732‒41.
Pyne JH, Fishburn P, Dicker A, David M. Infiltrating basal cell carcinoma: a stellate peri-tumor dermatoscopy pattern as a clue to diagnosis. Dermatol Pract Concept 2015; 5(2): 21‒6.
Tiodorović D, Jović A, Popović D, Kocić, Ignjatović A, Antonijević J, Veličković F. Dermoscopic Features of Basal Cell Carcinoma. Acta Fac Med Naiss 2018; 35(4): 273-81.
Reiter O, Mimouni I, Gdalevich M, Marghoob AA, Levi A, Hodak E, et al. The diagnostic accuracy of dermoscopy for basal cell carcinoma: a systematic review and meta-analysis. J Am Acad Dermatol 2019; 80(5): 1380‒8.
Dinnes J, Deeks JJ, Chuchu N, Matin RN, Wong KY, Aldridge RB, et al. Visual inspection and dermoscopy, alone or in com-bination, for diagnosing keratinocyte skin cancers in adults. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults. Cochrane Database Syst Rev 2018; 12(12): CD011901.
U.S. Preventive Services Task Force. Screening for skin cancer: US Preventive Services Task Force recommendation state-ment. Ann Intern Med 2009; 150(3): 188‒93.
Argenziano G, Zalaudek I, Hofmann-Wellenhof R, Bakos RM, Bergman W, Blum A, et al. Total body skin examination for skin cancer screening in patients with focused symptoms. J Am Acad Dermatol 2012; 66(2): 212‒9.
Federman DG, Kravetz JD, Kirsner RS. Skin cancer screening by dermatologists: prevalence and barriers. J Am Acad Dermatol 2002; 46(5): 710‒4.
Aitken JF, Janda M, Elwood M, Youl PH, Ring IT, Lowe JB. Clin-ical outcomes from skin screening clinics within a community-based melanoma screening program. J Am Acad Dermatol 2006; 54(1): 105‒14.
Lookingbill DP. Yield from a complete skin examination: find-ings in 1157 new dermatology patients. J Am Acad Dermatol 1988; 8(1 Pt 1): 31‒7.
Ahnlide I, Bjellerup M. Accuracy of Clinical Skin Tumour Di-agnosis in a Dermatological Setting. Acta Derm Venereol 2013; 93(3): 305–8.
American Cancer Society. Cancer Facts & Figures 2020. Atlanta: American Cancer Society; 2020. Available from: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2020.html. Accessed October 25.
Zalaudek I, Kittler H, Marghoob AA, Balato A, Blum A, Dalle S, et al. Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter study. Arch Dermatol 2008; 144(4): 509‒13.
Nelson SA, Scope A, Rishpon A, Rabinovitz HS, Oliviero MC, Laman SD, et al. Accuracy and confidence in the clinical diag-nosis of basal cell cancer using dermoscopy and reflex confocal microscopy. Int J Dermatol 2016; 55(12): 1351‒6.